Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2019 Jul 19:8:85-96.
doi: 10.2147/IPRP.S185663. eCollection 2019.

Screening tools for detecting problematic opioid use and potential application to community pharmacy practice: a review

Affiliations

Screening tools for detecting problematic opioid use and potential application to community pharmacy practice: a review

Bryn Lindley et al. Integr Pharm Res Pract. .

Abstract

Problematic opioid use, constituted by a myriad of conditions ranging from misuse to use disorders, has continued to receive an increasing amount of attention in recent years resulting from the high use of opioids in the United States coinciding with morbidity and mortality. Deaths from drug overdoses increased by over 11% between 2014 and 2015, which supports the need for identification of problematic opioid use in additional health care settings. One of these settings is community pharmacy. The community pharmacy is a unique health service setting to identify and potentially intervene with patients at risk of or exhibit problematic opioid use. Problematic opioid use can be identified using one of the various screening tools in conjunction with evaluating prescription drug monitoring systems. A total of 12 tools were identified that could be employed in community pharmacy settings for identifying problematic opioid use. This review highlights these tools and strategies for use that can be utilized in the community pharmacy, which should be adapted to individual pharmacy settings and local needs. Future research should assess pharmacy personnel's knowledge and perceptions of problematic opioid use and associated screening tools and interventions, which tools can be most effectively used in a community pharmacy, workflow needs to implement problematic opioid use screenings, and the impact of pharmacist engagement in problematic opioid use screening on patient clinical outcomes.

Keywords: community pharmacy; opioid use; opioid use disorder; screening tool.

PubMed Disclaimer

Conflict of interest statement

Dr Cochran is partly supported by grants from the National Institute on Drug Abuse (NIDA: R21DA04373502; UG1DA049444). The authors report no other conflicts of interest in this work.

References

    1. Passik SD, Kirsh KL, Casper D. Addiction-related assessment tools and pain management: instruments for screening, treatment planning, and monitoring compliance. Pain Med. 2008;9(Suppl 2):S145–S166. doi:10.1111/j.1526-4637.2008.00486.x - DOI
    1. SAMHSA. Behavioral Health Trends in the United States: Results from the 2017 National Survey on Drug Use and Health. Rockville, MD: Substance Abuse and Mental Health Services Administration; 2018.
    1. SAMHSA. Key Substance Use and Mental Health Indicators in the United States: Results from the 2017 National Survey on Drug Use and Health (HHS Publication No. SMA 18-5068, NSDUH Series H-53). Rockville, MD: Substance Abuse and Mental Health Services Administration, Center for Behavioral Health Statistics and Quality; 2018.
    1. Seth P, Scholl L, Rudd R, Bacon S. Overdose deaths involving opioids, cocaine, and psychostimulants—United States, 2015–2016. MMWR Morb Mortal Wkly Rep. 2018;67:349–358. - PMC - PubMed
    1. N K. The economic burden of opioid abuse: updated findings. J Manag Care Spec Pharm. 2017;23(4):427–445. - PMC - PubMed

LinkOut - more resources